DUBAI, U.A.EPRNewswire/ -- Future Market Insights' latest study has forecast the global sleep apnea diagnostic systems market to report prolific growth through 2021. Growth registered will be steered by the rising prevalence of sleep disorders and cases of undiagnosed sleep apnea cases around the world.

Long-term growth prospects for sleep apnea diagnostic systems market remain positive, with sales expected to surpass over US$ 5.4 Bn during the forecast period (2021-2031). With increasing awareness about the adverse health impacts of untreated sleep apnea, adoption of polysomnography (PSG) devices is set to rise across India, China, and Brazil.

With increasing incidence lifestyle disorders such as depression, obesity, and diabetes across the globe, there has been a considerable rise in the cases of sleep apnea. Due to surge in the cases of sleep disorders, hospitals and sleep centers are increasing the adoption of sleep apnea diagnostic devices.

Following the outbreak of COVID-19, people have become more aware and conscious about their mental health. Due to this, patients with obesity and other lifestyle disorders are lining up for diagnosis of sleep disorder.  

During the FQ-20, there was substantial increase in the cases of obstructive sleep apnea, especially in the U.S. According to the American Academy of Sleep Medicine, over 936 million people worldwide suffer from sleep apnea and half of them needs treatment. 

On the back of this, sleep centers and clinics are increasing the adoption of PSG and advanced medical wearable devices. Demand for advanced wearable devices to track patients' sleep pattern or lack of sleep has therefore increased in hospitals and home care settings, alike.  

"Growing pool of patient with undiagnosed sleep apnea and surging awareness regarding the condition will increase the adoption of sleep apnea diagnostic systems across the globe. On the back of this, the demand for advanced sleep apnea diagnostic devices will rise," says the Future Market Insights analyst. 

Key Takeaways from Sleep Apnea Diagnostic Systems Market Survey 

  • In terms of product, polysomnography (PSG) devices are highly sought-after in sleep apnea diagnostic systems market
  • Sleep centers and clinics are expected to remain primary end-users
  • Rising incidence of sleep disorders and growing patient pool of undiagnosed sleep apnea cases in the U.S. will create incremental opportunities for the market
  • China is expected to emerge as lucrative market backed by technological advancements in the healthcare sector
  • Prevalence of lifestyle disorders such as obesity and depression have increased the cases of sleep apnea in Brazil, providing boost to the market demand
  • India will witness incremental growth opportunities owing to the extensive adoption of PSG devices and growing cases of untreated and undiagnosed cases of sleep apnea

Key Drivers  

  • Expanding pool of undiagnosed patients of sleep apnea will provide growth opportunities for sleep apnea diagnostic systems market
  • Favorable government initiatives adopted to educate people regarding the ill effects of undiagnosed sleep apnea will accelerate demand
  • Growing use of oral devices and home sleep care systems for patients comfortable in home care setting is pushing the market growth
  • Increasing number of local players venturing into sleep apnea market will bolster the market growth

Key Restraints 

  • ·  High cost of continuous positive airway pressure (CPAP) machine for the treatment of obstructive sleep apnea might burden the patients, especially in emerging economies, restraining the growth 
  • ·  While most countries don't cover the cost of sleep apnea diagnostic machine, complex reimbursements policies and high expenses might create hurdle for home care patients  

Competitive Landscape 

Corporation are the top 5 players.  

These players contribute over 80-85% of global revenue in the sleep apnea diagnostic systems market. Key players in this market are focusing on product launches and innovation to increase the sales. 

They are also forming alliances with other key players to expand their customer base and meet surging requirement of sleep apnea diagnostic systems.  

Further, some of the companies are investing heavily in research activities to develop advanced sleep apnea diagnostic systems to strengthen their position in the industry. 

For instance,  

  • In June 2021, leading player Somnoware of digital sleep and respiratory health management announced its collaboration with Itamar Medical, another leading Israeli sleep apnea company. The company announced the integration of the WatchPAT One device with its Sleep Device Interface (SDI) that provides manufacturer independent, browser-based interface of diagnostic device operations.
  • Another key company, Oventus Medical, in June 2021, announced its partnership with Aeroflow Healthcare to provide Oventus' obstructive sleep apnea treatment solution to patients through sleep clinics.
  • In August 2021, ZOLL® Medical Corporation, an Asahi Kasei company, leading manufacturer of medical devices and related software solutions, announced the approval of the U.S. Food and Drug Administration (FDA) for the remedē® EL-X System to treat moderate to severe central sleep apnea (CSA) in adult patients.

Some of the leading players operating in the sleep apnea diagnostic systems market profiled by Future Market Insights are: 

  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Braedon Medical Corporation
  • Advanced Brain Monitoring Inc.
  • SOMNOmedics GmbH
  • ResMed Inc.
  • BMC Medical Co. Ltd.
  • Natus Medical Incorporated
  • MGC Diagnostics Corporation
  • Cleveland Medical Devices Inc.

More Valuable Insights on Market 

Future Market Insights, in its new report presents an unbiased analysis of the global sleep apnea diagnostic systems market. The study analyzes crucial trends that are currently determining the growth of the market. Find compelling insights of the market with a detailed segmentation on the basis of: 

By Product: 

  • Polysomnography (PSG) Devices
    • Ambulatory PSG Monitoring Devices
    • Clinical PSG Monitoring Devices
    • Sleep Apnea Screening Devices
  • Nasal Flow Sensors
  • Peripheral Capillary Oxygen Saturation (SPO2)
  • Actigraphy Monitoring Devices

By End-Users: 

  • Home Care Settings
  • Hospitals
  • Sleep Centers & Clinics

By Region: 

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan and China (APEJC)
  • Japan
  • Middle East & Africa (MEA)

Key Questions Covered in the Sleep Apnea Diagnostic Systems Market Report  

  • The report offers detailed insights into sleep apnea diagnostic systems demand outlook for 2021-2031
  • The market study also highlights projected sales growth for sleep apnea diagnostic systems market between 2021 and 2031
  • Sleep apnea diagnostic systems market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Sleep apnea diagnostic systems market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Explore FMI's Extensive Coverage on Healthcare Domain 

Pediatric Sports Medicine Market: In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for pediatric sports medicine market. The report tracks the global sales of pediatric sports medicine in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on sports medicine in general, and single-pediatric sports medicine in particular. 

Orthomolecular Medicine Market: The global orthomolecular medicine market report by FMI sheds light on the important growth dynamics expected to prevail across the 2021-2031 assessment period. Statistics of key segments have been provided across prominent geographies, along with a detailed mapping of the global competitive landscape, rendering this insight a highly effectual one. 

Personalized Medicine Market: In its new report, the Future Market Insights (FMI) offers an exhaustive overview of the global personalized medicine market with focus on the key market dynamics, including drivers, trends, opportunities, restraints, and detailed information about the global advanced wound debridement products market structure. The market study presents exclusive information about how the market will grow during the forecast period. 

-Ends-

About Future Market Insights (FMI) 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. 

Contact: 
Future Market Insights, 
1602-6 Jumeirah Bay X2 Tower, 
Plot No: JLT-PH2-X2A, 
Jumeirah Lakes Towers, Dubai, 
United Arab Emirates 
For Sales Enquiries: sales@futuremarketinsights.com  
For Media Enquiries: press@futuremarketinsights.com  
Website: https://www.futuremarketinsights.com/   
Report: https://www.futuremarketinsights.com/reports/sleep-apnea-diagnostic-system-market  
Press Release Source: https://www.futuremarketinsights.com/press-release/sleep-apnea-diagnostic-system-market 

SOURCE Future Market Insights

CONTACT: +1-347-918-3531 / + 44 (0) 20 7692 8790

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.